Sanofi and Regeneron’s Dupixent gets more positive feedback from US FDA
Dupixent was launched in the US in April 2017 for the treatment of moderate-to-severe eczema
The US Food & Drug…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.